Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tymon Pol"'
Autor:
Christopher B Granger, Tymon Pol, Johan Lindbäck, M Cecilia Bahit, JW Eikelboom, Renato Lopes
Publikováno v:
Open Heart, Vol 8, Iss 1 (2021)
Objectives Growth differentiation factor 15 (GDF-15) is a biomarker independently associated with bleeding and death in anticoagulated patients with atrial fibrillation (AF). GDF-15 is also used as one component in the more precise biomarker-based AB
Externí odkaz:
https://doaj.org/article/7e046438d01145f4bb029ceb1a74034f
Autor:
Ziad Hijazi, Lars Wallentin, Johan Lindbäck, John H. Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Christopher B. Granger, Renato D. Lopes, Tymon Pol, Salim Yusuf, Jonas Oldgren, Agneta Siegbahn
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 24 (2020)
Background To explore the pathophysiological features of ischemic stroke in patients with atrial fibrillation (AF), we evaluated the association between 268 plasma proteins and subsequent ischemic stroke in 2 large AF cohorts receiving oral anticoagu
Externí odkaz:
https://doaj.org/article/09faa38f34544078bc872e48e57b7a7c
Autor:
Tymon Pol, Claes Held, Johan Westerbergh, Johan Lindbäck, John H. Alexander, Marco Alings, Cetin Erol, Shinya Goto, Sigrun Halvorsen, Kurt Huber, Michael Hanna, Renato D. Lopes, Witold Ruzyllo, Christopher B. Granger, Ziad Hijazi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 3 (2018)
BackgroundDyslipidemia is a major risk factor for cardiovascular events. The prognostic importance of lipoproteins in patients with atrial fibrillation is not well understood. We aimed to explore the association between apolipoprotein A1 (ApoA1) and
Externí odkaz:
https://doaj.org/article/dd9977d5b6004d4fa020a383b51cf771
Autor:
Stuart J. Connolly, Agneta Siegbahn, Tymon Pol, Christopher B. Granger, Lars Wallentin, Ziad Hijazi, John H. Alexander, Salim Yusuf, John W. Eikelboom, Jonas Oldgren, Michael D. Ezekowitz, Renato D. Lopes, Johan Lindbäck
Aims Atrial fibrillation (AF) is associated with higher mortality. Biomarkers may improve the understanding of key pathophysiologic processes in AF that lead to death. Using a new multiplex analytic technique, we explored the association between 268
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f3eb2553a4f61fd6c1a399760f62ec
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-464159
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-464159
Autor:
Lars Wallentin, Salim Yusuf, Renato D. Lopes, John H. Alexander, Johan Lindbäck, Mikael Åberg, Jonas Oldgren, John W. Eikelboom, Ziad Hijazi, Tymon Pol, Christopher B. Granger, Agneta Siegbahn
BACKGROUND: Oral anticoagulants (OAC) in patients with atrial fibrillation (AF) prevent thromboembolic events, but are associated with significant risk of bleeding. OBJECTIVES: To explore associations between a wide range of biomarkers and bleeding r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::624c8e7038bea3045999894b28b28407
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-464157
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-464157
Autor:
John H. Alexander, Michael D. Ezekowitz, Elaine M. Hylek, Bernard J. Gersh, Raffaele De Caterina, Ziad Hijazi, Renato D. Lopes, Agneta Siegbahn, Christopher B. Granger, Johan Lindbäck, M. Cecilia Bahit, John W. Eikelboom, Lars Wallentin, Tymon Pol
Publikováno v:
Open Heart
Open Heart, Vol 8, Iss 1 (2021)
Open Heart, Vol 8, Iss 1 (2021)
ObjectivesGrowth differentiation factor 15 (GDF-15) is a biomarker independently associated with bleeding and death in anticoagulated patients with atrial fibrillation (AF). GDF-15 is also used as one component in the more precise biomarker-based ABC
Autor:
Tamila Heresztyn, Rafaele De Caterina, Christopher B. Granger, John Horowitz, Agneta Siegbahn, Ziad Hijazi, Philippe Steg, John H. Alexander, Renato D. Lopes, Johan Lindbäck, Johan Westerbergh, Tymon Pol, Lars Wallentin
Publikováno v:
Journal of the American College of Cardiology. 75:348
In patients with atrial fibrillation (AF), asymmetric and symmetric dimethylarginine (ADMA/SDMA) as well as conventional cardiac, inflammatory and coagulation biomarkers are associated with cardiovascular death, thromboembolic events and major bleedi
Autor:
Christopher B. Granger, Tymon Pol, John H. Alexander, Lars Wallentin, Jonas Oldgren, Ziad Hijazi, Agneta Siegbahn, Renato D. Lopes, Johan Lindbäck
Publikováno v:
European Heart Journal. 39
Autor:
Çetin Erol, Christopher B. Granger, Ziad Hijazi, Witold Rużyłło, Johan Westerbergh, Tymon Pol, Renato D. Lopes, Kurt Huber, Johan Lindbäck, Marco Alings, Shinya Goto, John H. Alexander, Michael G. Hanna, Claes Held, Sigrun Halvorsen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Dyslipidemia is a major risk factor for cardiovascular events. The prognostic importance of lipoproteins in patients with atrial fibrillation is not well understood. We aimed to explore the association between apolipoprotein A1 (ApoA1) and
Autor:
Christopher B. Granger, Ziad Hijazi, Marco Alings, Shinya Goto, Witold Rużyłło, Renato D. Lopes, Michael G. Hanna, Sigrun Halvorsen, Kurt Huber, Claes Held, Tymon Pol, A. Siegbahn, Çetin Erol, Lars Wallentin, John H. Alexander
Publikováno v:
European Heart Journal. 38